Lesico Ltd (TLV:LSCO)

Sage Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	180	204	135	131	313	226
Market Cap Growth	14.37%	51.27%	2.56%	-57.99%	38.26%	-2.64%
Enterprise Value	171	149	123	82	295	188
Last Close Price	3.54	3.90	2.53	2.39	5.69	4.57
PE Ratio	12.12	10.23	15.07	7.99	-	26.47
PS Ratio	0.17	0.20	0.17	0.16	0.48	0.38
PB Ratio	0.79	0.89	0.64	0.66	1.73	1.46
P/TBV Ratio	0.85	0.95	0.68	0.71	1.97	1.75
P/FCF Ratio	9.57	9.32	-	48.97	-	-
P/OCF Ratio	6.70	6.84	85.73	11.35	28.80	17.41
EV/Sales Ratio	0.16	0.14	0.15	0.10	0.45	0.31
EV/EBITDA Ratio	5.65	5.92	6.43	2.27	-	11.97
EV/EBIT Ratio	10.86	7.86	9.84	2.81	-	22.75
EV/FCF Ratio	9.05	6.80	-	30.57	-	-
Debt / Equity Ratio	0.38	0.25	0.33	0.50	0.70	0.60
Debt / EBITDA Ratio	2.91	1.70	2.60	2.38	-	4.57
Debt / FCF Ratio	4.54	2.60	-	37.06	-	-
Asset Turnover	1.66	1.61	1.27	1.36	1.18	1.38
Inventory Turnover	105.05	114.70	91.23	90.33	68.65	73.82
Quick Ratio	1.31	1.28	1.24	1.24	1.34	1.46
Current Ratio	1.34	1.37	1.37	1.41	1.52	1.54
Return on Equity (ROE)	7.22%	9.26%	4.70%	7.29%	-6.20%	5.18%
Return on Assets (ROA)	1.42%	1.83%	1.24%	2.91%	-2.32%	1.18%
Return on Capital (ROIC)	3.06%	4.17%	2.71%	6.03%	-4.61%	2.41%
Return on Capital Employed (ROCE)	5.70%	7.30%	5.30%	11.30%	-	3.60%
Earnings Yield	8.60%	9.78%	6.64%	12.52%	-2.84%	3.78%
FCF Yield	10.45%	10.73%	-5.18%	2.04%	-2.07%	-2.42%
Dividend Yield	5.51%	4.03%	3.11%	-	-	1.09%
Payout Ratio	19.34%	15.04%	44.71%	-	-	35.08%
Buyback Yield / Dilution	-4.78%	-	-	-5.60%	-6.14%	-
Total Shareholder Return	0.73%	4.03%	3.11%	-5.60%	-6.14%	1.09%

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.